Breast Cancer News and Research

Latest Breast Cancer News and Research

Refusal to give new breast cancer drug lands health authority in court

British health secretary Patricia Hewitt has become embroiled in a row over the provision of the revolutionary breast cancer drug Herceptin.

9 Nov 2005

Introgen's INGN 241 combined with Celebrex kills breast cancer cells

Introgen Therapeutics, Inc. today reported the publication of preclinical data demonstrating that INGN 241 works synergistically with celecoxib (Celebrex) marketed by Pfizer to inhibit the growth and increase apoptosis (cell death) of breast cancer cells.

8 Nov 2005

Women refuse follow-up tests for breast cancer

In a study of women with breast cancer, Kaiser Permanente researchers and others examined characteristics of women who refused recommended follow-up testing after a positive breast cancer screening test, or a visit to a medical provider for breast cancer symptoms.

8 Nov 2005

Herceptin results beg questions on equal access to expensive drugs

The recent press coverage on the use of Herceptin (brand name for the drug trastuzumab) for treating breast cancer in its early stages shows that issues of equal access to costly but effective drugs must be confronted, says an editorial in the British Medical Journal.

7 Nov 2005

Largest study to date on risk factors associated with primary biliary cirrhosis

A case-control study of more than 2000 people has identified a number of factors that may induce primary biliary cirrhosis (PBC) in genetically susceptible individuals. These include a history of urinary tract infections, hormone replacement therapy, tobacco use, and nail polish use.

3 Nov 2005

Ospemifine may also help to prevent breast cancer

A tamoxifen-like drug developed by UC Davis and Finnish researchers, now in clinical testing as a treatment for vaginal atrophy, may also help to prevent breast cancer, two preliminary studies suggest.

3 Nov 2005

Substance found in evening primrose oil inhibits breast cancer gene

Gamma-linolenic acid (GLA), a substance in evening primrose oil and several other plant oils used in herbal medicine, inhibits action of Her-2/neu, a cancer gene that is responsible for almost 30 percent of all breast cancers, Northwestern University researchers report.

3 Nov 2005

Study examines cancer risks after cancer diagnosis in family

After a person is diagnosed with cancer, increased surveillance among their family members may result in the earlier detection of asymptomatic familial cancers.

3 Nov 2005

Diet high in soy does not increase the risk of uterine cancer in postmenopausal women

Cline said there has been much debate about whether high levels of dietary soy are safe for postmenopausal women. Soy products are sometimes sold as a natural alternative to traditional estrogen therapy, which does increase the risk of endometrial cancer.

3 Nov 2005

Top cancer fighting foods

According to a newly published series of studies scientists have found that eating cabbage, cooking meat with garlic and even rubbing yourself all over with extract of broccoli can all help reduce the risk of cancer.

2 Nov 2005

First study to confirm the benefit of anti-angiogenic therapy in patients with breast cancer

Results from the first and only interim analysis of an important trial assessing the potential of Herceptin (trastuzumab) to improve disease-free survival (DFS) in HER-2 positive breast cancer patients after adjuvant chemotherapy, have shown that Herceptin affords a significant survival advantage.

1 Nov 2005

Mammograms a big factor in the fight against breast cancer

A new study has come down solidly on the side of routine screening mammograms as a preventative measure in the fight against cancer.

27 Oct 2005

Early detection and improved treatment have contributed almost equally to the substantial decrease in breast cancer

Early detection through screening mammography and improved adjuvant treatment have contributed almost equally to the substantial decrease in breast cancer death rates over the past 10 to 15 years, researchers conclude in an unprecedented effort to parse out the factors that have led to the decline.

27 Oct 2005

Way now clear for use of costly breast cancer drug throughout UK

Health managers in the UK have virtually been ordered to pay for the drug Herceptin for women with an aggressive form of breast cancer in its early stages.

26 Oct 2005

Fight over billboards linking cancer to abortion

An anti-abortion group, Life Canada, has put up three billboards in Alberta that display a large pink ribbon and the words "stop the cover up".

26 Oct 2005

Doctors call for urgent review of UK cancer initiative

Hospital doctors are calling for an urgent review of the UK Government’s two-week cancer wait, saying there’s no evidence that the initiative has had any impact on survival rates.

26 Oct 2005

Can strength-training exercises reduce or prevent lymphedema symptoms in breast cancer?

In a novel research study to begin this week at the Abramson Cancer Center of the University of Pennsylvania, Kathryn Schmitz, PhD, MPH, Assistant Professor in Epidemiology, will help to determine the extent to which a slowly progressive program of strength-training exercises is safe for breast cancer survivors with and without symptoms of lymphedema.

25 Oct 2005

Early diagnosis guarantees therapeutic success in breast cancer

Breast cancer is the most common tumour amongst the female population. In recent years its prevalence has increased considerably without the reasons thereof being very clear, although lifestyle changes such as first pregnancy taking place at a later age or the reduction in the period of breast-feeding may play an important role.

25 Oct 2005

Cholesterol levels and use of statins are not associated with breast cancer risk

Although some evidence suggests that statins (the most commonly used type of lipid-lowering drugs) may inhibit tumor development and may work in combination with chemotherapy drugs against cancer, studies on the association between the use of statins and breast cancer have had conflicting results

25 Oct 2005

Physical and emotional impact of breast cancer

The psychological and physical effects of breast cancer are being examined in a first-time study that tracks women in the first five years following their diagnosis.

25 Oct 2005